What Is Floppy Iris Syndrome and How Does It Affect Cataract Surgery?

If you take Flomax (tamsulosin) or a similar medication for prostate or urinary symptoms, your cataract surgeon needs to know before the day of surgery. A medication class called alpha-1 blockers changes how the iris behaves inside the eye, producing a pattern surgeons call intraoperative floppy iris syndrome, or IFIS. It is common, it is manageable, and it is one of the most important pieces of information you can bring to your cataract consult. This article explains what IFIS is, why it matters, and how a prepared surgeon operates differently when it is expected.

What is intraoperative floppy iris syndrome?

Intraoperative floppy iris syndrome was first described by Chang and Campbell in the Journal of Cataract and Refractive Surgery in 2005. They defined three intraoperative findings that together make up the syndrome:

  • A floppy, billowing iris. The iris tissue moves with the fluid currents that normally circulate through the eye during phacoemulsification, where a stiffer iris would stay still.
  • Iris prolapse. The iris has a tendency to push toward and sometimes out of the small incisions the surgeon uses to access the lens.
  • Progressive miosis. The pupil, which the surgeon has pharmacologically dilated before the case, gradually constricts during surgery.

These findings are not a complication in the traditional sense. They are a pattern of iris behavior that makes cataract surgery more technically challenging. When the surgeon knows it is coming, the case is planned around it. When the surgeon does not know, the risk of complications such as posterior capsule rupture, iris trauma, and incomplete cataract removal goes up (AAO EyeNet).

The tamsulosin connection and why it is not only tamsulosin

Tamsulosin (Flomax) is the drug most strongly associated with IFIS. It is an alpha-1 adrenergic receptor antagonist, and its selectivity for the alpha-1A receptor is the reason it works well for symptoms of benign prostatic hyperplasia. The iris dilator muscle is rich in alpha-1A receptors, and that is why the same medication that relaxes the smooth muscle of the prostate also affects the iris.

In the original Chang and Campbell series, IFIS occurred in approximately 86% of eyes in patients with a history of tamsulosin, compared with about 15% of eyes in patients taking alfuzosin, a less selective alpha-1 blocker. Subsequent studies have consistently confirmed tamsulosin as the highest-risk agent, though risk is not zero with any of the following:

  • Alfuzosin (Uroxatral)
  • Silodosin (Rapaflo)
  • Doxazosin (Cardura)
  • Terazosin (Hytrin)
  • Saw palmetto, a supplement taken for prostate symptoms, associated with milder IFIS in case reports

A 2021 review in the peer-reviewed literature confirmed the association of tamsulosin use within 14 days of cataract surgery with an approximately 2.3-fold increase in serious postoperative complications compared with non-users (PMC8270016). This is not an argument to stop the medication; it is an argument to disclose it.

Why it matters: what the iris does during phacoemulsification

A standard cataract operation takes advantage of a well-dilated pupil. Eye drops given before surgery (phenylephrine, tropicamide, and occasionally atropine) open the pupil to 7 to 8 millimeters, giving the surgeon clear access to the cataract behind the iris. A stiff, well-dilated iris sits quietly during the case.

In an IFIS eye, three things can happen as soon as instruments enter the anterior chamber:

  • The iris begins to billow in the fluid flow, which can obscure the surgeon's view of the cataract and risks contact between instruments and iris tissue.
  • The iris drifts toward the incisions and can prolapse out, which can tear iris tissue and affect the postoperative pupil shape.
  • The pupil constricts progressively during the case, reducing the working window for the surgeon and raising the difficulty of removing the cataract cleanly.

None of these is catastrophic in a prepared case. Each becomes a real problem when the surgeon is surprised mid-procedure.

What a prepared surgeon does differently

When IFIS is expected, a cataract surgeon adjusts the case in three places: before surgery, at the start of surgery, and during the lens removal itself.

Preoperative medications

Several medications reduce the intraoperative behavior of the iris when given before or at the start of the case:

  • Topical atropine 1%, often dosed two to three times daily in the days before surgery, stiffens the iris and reduces mild IFIS features. One published series documented a reduction in mild IFIS from 86% to 60% with preoperative atropine.
  • Intracameral phenylephrine or epinephrine, given through a cataract incision at the start of surgery, re-expands the pupil and adds tone to the iris.
  • Omidria, a commercially available intracameral combination of phenylephrine 1% and ketorolac 0.3%, is added to the irrigating solution during surgery to maintain pupil size and reduce inflammation.

Pupil expansion devices

When medical dilation is not sufficient, a mechanical device holds the pupil open:

  • The Malyugin ring is a small, square-shaped flexible device inserted through the primary incision. It catches the pupillary margin at four points and holds the pupil open at 6.25 or 7 millimeters. It is the most commonly used IFIS tool in 2026.
  • Iris hooks are four flexible retractors inserted through separate small incisions. They are typically used when a Malyugin ring is not a good fit, such as a very small pupil or unusual iris anatomy.
  • Other iris expansion rings (for example, the I-Ring and Iris Expander) are available in specific settings.

Modified surgical technique

A prepared surgeon also adjusts the fluid dynamics and viscoelastic choices of the operation:

  • Lower phaco flow and aspiration settings reduce iris motion in the chamber.
  • Dispersive viscoelastic (for example, Healon 5) stays in the anterior chamber and holds the iris back from the operative field.
  • Shortened incisions and careful incision architecture reduce iris prolapse through the wounds.

Each of these adjustments is a small thing on its own. Together, they convert a potentially difficult case into a predictable one.

Should you stop tamsulosin before cataract surgery?

This is the question patients ask most often, and the short answer is: do not change your medication without involving the prescriber who put you on it.

Stopping tamsulosin shortly before surgery does not reliably prevent IFIS. The medication's effect on alpha-1A receptors in the iris dilator muscle can persist for months to years after discontinuation, and IFIS has been reported in patients who took tamsulosin briefly and stopped years earlier. That is why every cataract surgeon asks about past as well as current tamsulosin use.

The right path when you are taking tamsulosin and need cataract surgery is coordination. Your urologist (or whichever prescriber started the medication) is managing your urinary symptoms or hypertension, and they may have a reason to keep you on the medication, switch you to an alternative, or temporarily pause it depending on your specific situation. Your ophthalmologist is planning your cataract surgery and will prepare the case for IFIS whether or not the medication has been adjusted. The two conversations are connected but separate, and you should have both.

Do not stop on your own. Tell each clinician about the other.

Outcomes when IFIS is expected

The data on cataract surgery in IFIS-risk patients is reassuring when surgery is planned. Large published series in the last decade document that, with preoperative atropine, intracameral mydriatics, and a pupil expansion device when needed, the rate of serious intraoperative complications drops toward the rate seen in non-IFIS cases. The 2.3-fold complication risk documented in the Canadian cohort discussed above applies specifically to patients where the IFIS risk was not managed proactively (PMC8270016).

In other words, the problem is not IFIS. The problem is an unprepared case. A subspecialty cataract surgeon who sees IFIS several times a week operates on IFIS-risk patients routinely and to the same visual outcome as other cataract patients.

What to tell your surgeon before your consult

Bring a complete medication list. Include:

  • Current prescription medications, including any alpha-1 blocker for prostate or urinary symptoms (tamsulosin, alfuzosin, silodosin, doxazosin, terazosin).
  • Past prescription medications that you stopped, even years ago, particularly alpha-1 blockers. IFIS risk persists after discontinuation.
  • Over-the-counter supplements, particularly saw palmetto.
  • The name of the prescriber who started any alpha-1 blocker, so coordination is easy if needed.

We also recommend asking these three questions at your consult:

  • Given my medication history, are you expecting IFIS during my surgery?
  • What is your plan for managing it? Atropine, Omidria, Malyugin ring, other?
  • Do you want to coordinate with my prescriber about the medication?

A clear answer to each means your surgeon's practice is mature on this question.

Candidacy framing for IFIS-risk patients

You can almost certainly proceed with cataract surgery if:

  • You take or have taken tamsulosin or another alpha-1 blocker and you have disclosed it.
  • Your surgeon has experience with IFIS and has a plan for your case.
  • There are no other complicating eye findings.

We would want to talk more if:

  • You have had prior eye trauma or prior eye surgery, which can add to the iris complexity.
  • You have pseudoexfoliation syndrome, which weakens the zonules that hold the natural lens.
  • You have a particularly small pupil that does not dilate well, even without IFIS.

This is not a reason to avoid cataract surgery. It is a reason to choose a surgeon and a practice that handle IFIS routinely.

Frequently Asked Questions

What is intraoperative floppy iris syndrome?

Intraoperative floppy iris syndrome, or IFIS, is a pattern of iris behavior during cataract surgery first described by Chang and Campbell in 2005. It has three features: a floppy, billowing iris that moves with fluid currents, a tendency of the iris to prolapse toward the surgical incisions, and progressive constriction of the pupil during the case.

Does tamsulosin (Flomax) cause floppy iris syndrome?

Tamsulosin is the strongest known association. In the original Chang and Campbell study, IFIS occurred in approximately 86% of eyes in patients with a history of tamsulosin, compared to about 15% for alfuzosin. The effect can persist after the medication is stopped, so even a prior history is important to disclose.

Should I stop taking tamsulosin before cataract surgery?

Do not stop or adjust tamsulosin without discussing it with the prescriber who put you on it, usually your urologist. The receptor effect on the iris dilator muscle can persist even after discontinuation, so stopping does not reliably eliminate IFIS. Tell your cataract surgeon that you take or have taken tamsulosin, and let your surgeon and prescriber coordinate.

Can cataract surgery still be done if I have IFIS?

Yes. Experienced cataract surgeons operate on IFIS-at-risk patients routinely. With preoperative planning and the right intraoperative tools, including pupil expansion devices such as the Malyugin ring and intracameral medications, surgery proceeds safely. Outcomes in prepared IFIS cases are close to those in non-IFIS cases.

What other medications can cause floppy iris syndrome?

IFIS has been reported with other alpha-1 blockers used for urinary symptoms, including alfuzosin, silodosin, doxazosin, and terazosin. Saw palmetto, a supplement used for prostate symptoms, has also been associated with milder IFIS. Always disclose every medication and supplement at your cataract evaluation.

What is a Malyugin ring?

The Malyugin ring is a small, flexible square-shaped device inserted through a cataract incision to hold the pupil open during surgery. It mechanically stabilizes the iris and keeps the pupil from constricting during phacoemulsification, which is the single most useful tool for managing IFIS.

What should I tell my cataract surgeon at my consultation?

Bring a complete list of your current and past medications, including prostate medications and supplements. Specifically disclose any history of tamsulosin, alfuzosin, silodosin, doxazosin, terazosin, or saw palmetto, even if you stopped years ago. Your surgeon plans the case differently when IFIS is expected.

Next steps

If you are preparing for cataract surgery and take a prostate or urinary medication, the next useful reads are our pages on cataract surgery recovery, cataract surgery side effects, and laser cataract surgery. When you are ready to schedule an evaluation, contact our team and bring your complete medication list to the first visit.

newsletter

Get useful insight and advice in your inbox.

* We don't share your data. See our Privacy Policy
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.